Zlotnikov Igor D, Kudryashova Elena V
Department of Chemistry, M.V. Lomonosov Moscow State University, Leninskie Gory, 1/11B, 119991 Moscow, Russia.
Pharmaceuticals (Basel). 2022 May 19;15(5):625. doi: 10.3390/ph15050625.
Rational search of a ligand for a specific receptor is a cornerstone of a typical drug discovery process. However, to make it more "rational" one would appreciate having detailed information on the functional groups involved in ligand-receptor interaction. Typically, the 3D structure of a ligand-receptor complex can be built on the basis of time-consuming X-ray crystallography data. Here, a combination of FTIR and fluorescence methods, together with appropriate processing, yields valuable information about the functional groups of both the ligand and receptor involved in the interaction, with the simplicity of conventional spectrophotometry. We have synthesized the "molecular containers" based on cyclodextrins, polyethyleneimines (PEI) or spermine with mannose-rich side-chains of different molecular architecture (reticulated, star-shaped and branched) with variable parameters to facilitate delivery to alveolar macrophages. We have shown that synthetic mannose-rich conjugates are highly affine to the model mannose receptor ConA: ≈ 10-10 M vs. natural ligand trimannoside (10 M). Further, it was shown that molecular containers effectively load levofloxacin (dissociation constants are 5·10-5·10 M) and the eugenol adjuvant (up to 15-80 drug molecules for each conjugate molecule) by including them in the cyclodextrins cavities, as well as by interacting with polymer chains. Promising formulations of levofloxacin and its enhancer (eugenol) in star-shaped and polymer conjugates of high capacity were obtained. UV spectroscopy demonstrated a doubling of the release time of levofloxacin into the external solution from the complexes with conjugates, and the effective action time (time of 80% release) was increased from 0.5 to 20-70 h. The synergy effect of antibacterial activity of levofloxacin and its adjuvants eugenol and apiol on was demonstrated: the minimum effective concentration of the antibiotic was approximately halved.
寻找与特定受体结合的配体是典型药物发现过程的基石。然而,为了使其更“合理”,人们希望获得有关配体 - 受体相互作用中涉及的官能团的详细信息。通常,配体 - 受体复合物的三维结构可以基于耗时的X射线晶体学数据构建。在此,傅里叶变换红外光谱(FTIR)和荧光方法相结合,并经过适当处理,以传统分光光度法的简单方式,产生了有关参与相互作用的配体和受体官能团的有价值信息。我们合成了基于环糊精、聚乙烯亚胺(PEI)或精胺的“分子容器”,其带有不同分子结构(网状、星形和支链)且具有可变参数的富含甘露糖的侧链,以促进向肺泡巨噬细胞的递送。我们已经表明,合成的富含甘露糖的缀合物对模型甘露糖受体伴刀豆球蛋白A具有高度亲和力:≈10^-10 M,而天然配体三甘露糖苷为10 M。此外,结果表明分子容器通过将左氧氟沙星(解离常数为5·10^-5·10 M)和丁香酚佐剂(每个缀合物分子多达15 - 80个药物分子)包含在环糊精腔中以及与聚合物链相互作用,有效地负载了它们。获得了高容量的星形和聚合物缀合物中左氧氟沙星及其增强剂(丁香酚)的有前景的制剂。紫外光谱表明,与缀合物形成的复合物中左氧氟沙星释放到外部溶液中的时间增加了一倍,有效作用时间(80%释放时间)从0.5小时增加到20 - 70小时。证明了左氧氟沙星及其佐剂丁香酚和芹子烯对的抗菌活性的协同作用:抗生素的最低有效浓度大约减半。